Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

An "exacerbate-reverse" strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease.

Munkacsi AB, Chen FW, Brinkman MA, Higaki K, Gutiérrez GD, Chaudhari J, Layer JV, Tong A, Bard M, Boone C, Ioannou YA, Sturley SL.

J Biol Chem. 2011 Jul 8;286(27):23842-51. doi: 10.1074/jbc.M111.227645. Epub 2011 Apr 13.

2.

Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.

Helquist P, Maxfield FR, Wiech NL, Wiest O.

Neurotherapeutics. 2013 Oct;10(4):688-97. doi: 10.1007/s13311-013-0217-2. Review.

3.

The potential of histone deacetylase inhibitors in Niemann - Pick type C disease.

Maceyka M, Milstien S, Spiegel S.

FEBS J. 2013 Dec;280(24):6367-72. doi: 10.1111/febs.12505. Epub 2013 Sep 23. Review.

4.

Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease.

Lloyd-Evans E, Platt FM.

Traffic. 2010 Apr;11(4):419-28. doi: 10.1111/j.1600-0854.2010.01032.x. Epub 2010 Jan 6. Review.

5.

Lysosome and endoplasmic reticulum quality control pathways in Niemann-Pick type C disease.

Schultz ML, Krus KL, Lieberman AP.

Brain Res. 2016 Oct 15;1649(Pt B):181-188. doi: 10.1016/j.brainres.2016.03.035. Epub 2016 Mar 26. Review.

6.

Niemann-Pick disease type C.

Vanier MT.

Orphanet J Rare Dis. 2010 Jun 3;5:16. doi: 10.1186/1750-1172-5-16. Review.

7.

Cholesterol in Niemann-Pick Type C disease.

Bi X, Liao G.

Subcell Biochem. 2010;51:319-35. doi: 10.1007/978-90-481-8622-8_11. Review.

8.

Steryl ester synthesis, storage and hydrolysis: A contribution to sterol homeostasis.

Korber M, Klein I, Daum G.

Biochim Biophys Acta. 2017 Dec;1862(12):1534-1545. doi: 10.1016/j.bbalip.2017.09.002. Epub 2017 Sep 6. Review.

PMID:
28888831
9.

[Annexins in Niemann-Pick type C disease].

Buszewska ME, Strzelecka-Kiliszek A, Tylki-Szymańska A, Bandorowicz-Pikuła J.

Postepy Biochem. 2007;53(2):169-73. Review. Polish.

PMID:
17969878
10.

The pathophysiology and mechanisms of NP-C disease.

Sturley SL, Patterson MC, Balch W, Liscum L.

Biochim Biophys Acta. 2004 Oct 11;1685(1-3):83-7. Review.

PMID:
15465429
11.

Niemann-Pick type C mutations cause lipid traffic jam.

Liscum L.

Traffic. 2000 Mar;1(3):218-25. Review.

12.

New agents and approaches to treatment in Niemann-Pick type C disease.

Pérez-Poyato MS, Pineda M.

Curr Pharm Biotechnol. 2011 Jun;12(6):897-901. doi: 1389-2010/11 $58.00+.00. Review.

PMID:
21235443
13.

The Niemann-Pick C proteins and trafficking of cholesterol through the late endosomal/lysosomal system.

Garver WS, Heidenreich RA.

Curr Mol Med. 2002 Aug;2(5):485-505. Review.

PMID:
12125814
14.

Molecular pathways for intracellular cholesterol accumulation: common pathogenic mechanisms in Niemann-Pick disease Type C and cystic fibrosis.

Cianciola NL, Carlin CR, Kelley TJ.

Arch Biochem Biophys. 2011 Nov;515(1-2):54-63. doi: 10.1016/j.abb.2011.08.012. Epub 2011 Sep 5. Review.

15.

Niemann-Pick Disease Type C: from molecule to clinic.

Tang Y, Li H, Liu JP.

Clin Exp Pharmacol Physiol. 2010 Jan;37(1):132-40. doi: 10.1111/j.1440-1681.2009.05235.x. Epub 2009 Jun 29. Review.

PMID:
19566836
16.

The pathogenesis of Niemann-Pick type C disease: a role for autophagy?

Pacheco CD, Lieberman AP.

Expert Rev Mol Med. 2008 Sep 10;10:e26. doi: 10.1017/S146239940800080X. Review.

17.

Current controversies in Niemann-Pick C1 disease: steroids or gangliosides; neurons or neurons and glia.

Erickson RP.

J Appl Genet. 2013 May;54(2):215-24. doi: 10.1007/s13353-012-0130-0. Epub 2013 Jan 5. Review.

PMID:
23292954
18.

Exacerbating and reversing lysosomal storage diseases: from yeast to humans.

Rajakumar T, Munkacsi AB, Sturley SL.

Microb Cell. 2017 Aug 25;4(9):278-293. doi: 10.15698/mic2017.09.588. Review.

19.

Sphingolipids and mitochondrial function, lessons learned from yeast.

Spincemaille P, Cammue BP, Thevissen K.

Microb Cell. 2014 Jun 25;1(7):210-224. doi: 10.15698/mic2014.07.156. Review.

Supplemental Content

Support Center